Rapid Test for COVID-19 Authorizeed by Health Canada Under the Interim Order

Accurate, efficient and trusted COVID-19 Rapid Antigen Testing Device intended to be used by trained clinical laboratory personnel.

Product features

High accuracy

Straight forward nasopharyngeal swab collection with clinically proven high accuracy results

Affordability

Any qualified Health Care professionals can easily use our three-step, cost-effective portable testing kit

Easy to use

Testing can be easily administered in almost any environment without additional special equipment. Easy to transport with no special storage requirements, a test kit is all you need.

Rapid result

Compare to standard RT-PCR tests which could take multiple days for patients to receive their results, Boson Antigen testers will show results within 15-20 minutes.

Performance statistics

Specificity
98.04%
Sensitivity
93.75%
Accuracy
97.48%

Who is it for?

Create safer environments for employees and customers using BOSON Rapid SARS-CoV-2 Antigen testing

Personal Care Services

  • Dentists, Chiropractors, RMT’s
  • Personal Services – Hair and Esthetic Salons

Hospitality and Events

  • Hospitality
  • Events Sector
  • Restaurants
  • Hotels

Production and Transportation

  • Warehouses
  • Manufacturing Plants

Public Sector Facilities

  • Schools
  • Nursing Homes
  • Prisons
  • Government Buildings

In conjunction with additional public health screening recommendations, regular BOSON Rapid SARS-CoV-2 Antigen testing by a trained clinical laboratory personnel specifically instructed and trained in vitro diagnostic procedures may assist with potential early detection of the virus to prevent further spread of Covid-19. This device is authorized by Health Canada under the Interim Order #323096

 

* Authorized use guidelines may vary by province so please contact your local regulators for confirmation on local professional use requirements.

Learn more

How it works

Rapid SARS-CoV-2 Antigen Test Card is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein from SARS-CoV-2 in nasopharyngeal swab specimens from individuals who are suspected of COVID-19 by their healthcare provider within the first 7 days of symptom onset.

1. Sample collection

Carefully insert the swab into the nostril and swab over the surface of the posterior nasopharynx.

1. Sample collection

2. Sample preparation

Add 8 drops of extraction buffer into the extraction tube. Leave the swab in the extraction buffer for 1 minute.

2. Sample preparation

3. Procedure

Add 3 drops of test specimen from the extraction tube on the test card and read the results at 15-20 minutes.

3. Procedure

4. Result interpretation

See IFU (Instructions For Use) sheet inside the device kit for more details.

4. Result interpretation

Download document

Please refer to the IFU information sheet and Full User Product Training document for detailed device information.

FAQs

For answers to commonly asked questions and more information about the Boson Rapid SARS Co-V2 device, please visit our FAQs page

See questions

Contact us

For more information on the product and distribution opportunities, please contact us